UNSPSC 51333409: Tolpiprazole

This classification denotes an antipsychotic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8XP74P4HO3. European Medicines Agency schedules Tolpiprazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11174MIG. Tolpiprazole generally arises in the molecular formula C17H24N4.

UNSPSC 51333409 Tolpiprazole (Commodity) does not align with the recent state and local procurement activity tagged under this code. The single recent opportunity on record—Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026—solicits naloxone and safe drug deactivation systems, not tolpiprazole, a proton-pump inhibitor used to treat gastroesophageal reflux disease. This mismatch suggests either a coding error in the source system or that the code is being misapplied to opioid-antagonist procurement. The source provides no evidence of tolpiprazole being purchased by state or local governments under this code.

Seminole County's solicitation—an IFB with a response deadline of July 26, 2023—requests 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The contract includes a two-year initial term with a one-year renewal option and is potentially funded through FEMA. Bidders must comply with E-Verify, drug-free workplace certification, and federal environmental regulations. Without additional recent opportunities or issuing bodies documented under this code, no reliable geographic spread or issuing-body pattern can be established.